Entrada Therapeutics Inc (TRDA) financials · rev $25.4M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Entrada Therapeutics Inc (TRDA) rev $25.4M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $25.4M | $210.8M |
| Operating Income | -$157.9M | $47.0M |
| Net Income | -$143.8M | $65.6M |
| EPS (Diluted) | -$3.47 | $1.68 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $377.4M | $526.3M |
| Current Assets | $306.3M | $440.0M |
| Cash & Equivalents | $90.4M | $101.2M |
| PP&E | $7.31M | $10.9M |
| Total Liabilities | $71.2M | $97.6M |
| Current Liabilities | $24.5M | $39.5M |
| Shareholders' Equity | $306.1M | $428.7M |
| Retained Earnings | -$273.1M | -$129.3M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$128.5M | -$41.6M |
| CapEx | $1.04M | $3.16M |
| Investing Cash Flow | $116.8M | -$27.8M |
| Financing Cash Flow | $887.0K | $103.0M |
| Net Change in Cash | -$10.8M | $33.6M |
| Free Cash Flow | -$129.6M | -$44.7M |
FAQ
What is TRDA P/E and revenue?
Entrada Therapeutics Inc (TRDA) rev $25.4M.
What is TRDA revenue?
Entrada Therapeutics Inc last cached revenue is $25.4M (FY2025).
Is TRDA profitable?
Entrada Therapeutics Inc last cached net income is -$143.8M (FY2025).
What are TRDA total assets?
Entrada Therapeutics Inc last cached total assets are $377.4M (FY2025).
What is TRDA free cash flow?
Entrada Therapeutics Inc last cached free cash flow is -$129.6M (FY2025).
Not investment advice. Cached statements, not a live tape.